Relates to authorizing certain providers of services to administer and dispense methadone or other controlled substances

2025 Regular Session Introduced by Tony Simone

Authorizes certain service providers to administer and dispense methadone or other controlled substances, expanding access to treatment beyond traditional opioid programs.

REFERRED TO ALCOHOLISM AND DRUG ABUSE

Summary: Bill A 6247

Title: Relates to authorizing certain providers of services to administer and dispense methadone or other controlled substances
Status: Referred to Alcoholism and Drug Abuse
Introduced: February 27, 2025
Sponsor: Tony Simone (primary)

Overview

Bill A 6247 proposes to authorize certain providers of services to administer and dispense methadone or other controlled substances. The legislative action logged shows the bill being introduced on February 27, 2025 and referred the same day to the Assembly committee on Alcoholism and Drug Abuse. The text of the bill is not provided here, so specifics about which providers would gain authority, under what conditions, or how oversight would be structured are not detailed in the available information.

What the bill would do (inferred from the title)

Expand or clarify authority for certain service providers to administer methadone and possibly other controlled substances.

Potentially establish qualifications, training, licensing requirements, or supervision standards for these providers.

Determine procedural or regulatory conditions under which administration and dispensing may occur, including safety and monitoring safeguards.

Note: The exact scope, criteria for eligible providers, required standards, and enforcement mechanisms would be defined in the bill’s text.

Who would be affected

Providers of services that would be authorized to administer or dispense methadone or other controlled substances (subject to the bill’s specific provisions).

Patients and clients receiving methadone or other controlled substances through these providers, particularly in settings not previously authorized.

State regulatory or oversight entities responsible for licensing, compliance, and monitoring of approved providers.

Procedural and timeline aspects

Introduced: February 27, 2025.

Action: Referred to the Assembly Committee on Alcoholism and Drug Abuse on the same date.

The record also lists the same committee referral twice on February 27, 2025, which appears to be a duplication in the action log rather than two distinct steps.

Legislative context and related bills

Related/A companion bills:

A 8620 (prior-session)
S 3764 (companion) — listed twice, indicating Senate counterpart.

The existence of a prior-session bill (A 8620) and Senate companions (S 3764) suggests parallel or continuing interest in expanding provider authority for methadone or related substances.

Potential impacts and considerations

Access: Could improve or broaden access to methadone treatment in settings beyond traditional opioid treatment programs.

Safeguards: Likely to raise questions about credentials, training, patient safety, monitoring, and abuse prevention; details would determine risk/benefit balance.

Costs and implementation: Fiscal and administrative implications would depend on the final provisions, including any required infrastructure, supervision, or reporting systems.

Public health implications: May influence treatment availability, continuity of care, and coordination with addiction services.

Next steps for readers

Monitor for further action, including committee hearings, amendments, and eventual floor votes.

Review the bill’s full text for precise definitions, eligibility criteria, required standards, and funding or fiscal notes once released.